An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A person online described switching weight-loss medicines and asked for dosing advice. They had been using Wegovy (a brand of semaglutide) and lost a lot of weight but found it too expensive. They then obtained "grey market" retatrutide and used up to 4 mg, felt better body composition but developed severe anhedonia (loss of pleasure). Now they have switched to tirzepatide at 2.5 mg and feel hungry, and they’re asking whether to increase the dose faster and what dose to aim for. Retatrutide and tirzepatide are both drugs that mimic hormones your gut sends to your brain after you eat. Semaglutide (Wegovy/Ozempic) copies one such hormone that reduces appetite. Tirzepatide copies two hormones and tends to reduce appetite and lower blood sugar even more. Retatrutide is a newer experimental peptide that targets three hormone pathways, aiming for even stronger weight loss effects. Calling something "peptide" just means it’s a small protein-like molecule that can talk to receptors in the body to change hunger and metabolism. The snippet is a single anonymous user report — an anecdote — not a controlled study. It describes personal experiences: semaglutide at prescribed doses helped them lose 40 pounds; unregulated retatrutide seemed to change body composition but caused troubling mood effects; tirzepatide at 2.5 mg is currently leaving them hungry. Anecdotes can be useful for clues but don’t prove what will happen for most people. Clinical trials give averages across many people and monitor safety; a single person's reaction can be unusual or tied to other factors like dose, purity of the "grey" drug, or mental health. Why this matters is practical: people are experimenting with these peptides to manage weight because they can be very effective. Knowing that different drugs and doses affect appetite, mood, and energy differently helps someone decide whether to continue, change dose, or seek medical supervision. If a drug caused significant anhedonia, that is important to notice — mental side effects can be as impactful as physical ones. Anyone thinking of changing dose or switching drugs should ideally do so with a healthcare provider who knows their medical history. There are important caveats and risks. “Grey market” or sourced drugs without a prescription can be impure, mislabeled, or unsafe. Dosing schedules for approved drugs are based on clinical trials that gradually increase dose to reduce side effects; increasing faster can raise the chance of nausea, dizziness, or worse mood changes. Tirzepatide is prescription-only and can cause gastrointestinal side effects, low blood sugar in people on diabetes meds, and possibly mood changes in some people. Retatrutide is experimental; its safety profile is not fully established. If someone experiences severe anhedonia or other worrying symptoms, they should stop and contact a clinician. Bottom line: personal reports are interesting but not a dosing guide — consult a doctor, avoid unregulated products, and be cautious about changing doses quickly.
Source: r/Peptides